Serum Collection Study for Assay Development

NCT07205289 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-10-03

No results posted yet for this study

Summary

The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation

Conditions

  • Pneumococcal Disease, Invasive
  • Pneumococcal Disease

Interventions

BIOLOGICAL

Gamma-PN

Killed whole-cell pneumococcal vaccine

Sponsors & Collaborators

  • GPN Vaccines

    lead INDUSTRY

Principal Investigators

  • Eve Kennedy, PhD · GPN Vaccines Ltd

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-01-31
Completion
2026-06-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07205289 on ClinicalTrials.gov